Timothy R. Koves

Timothy R. Koves

Auto-generated profile, based on publicly available information

Timothy R. Koves

Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, NC 27701, USA

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2008 in Cell Metabolism
Verified
Journal Article
Closed access
TKTimothy R. Koves
Timothy R. Koves
JUJohn R. Ussher
John R. Ussher
RNRobert C. Noland
Robert C. Noland
DSDorothy Slentz
Dorothy Slentz
MMMerrie Mosedale
Merrie Mosedale
DMDeborah M. Muoio
Deborah M. Muoio

23 February 2016 in Circulation
Verified
Journal Article
Closed access
PDF file
GAGregory Aubert
Gregory Aubert
OMOla J. Martin
Ola J. Martin
JHJulie L. Horton
Julie L. Horton
LLLing Lai
Ling Lai
RVRick B. Vega
Rick B. Vega
DKDaniel P. Kelly
Daniel P. Kelly
Background—: Significant evidence indicates that the failing heart is energy starved. During the development of heart failure, the capacity of the heart to utilize fatty acids, the chief fuel, is diminished. Identification of alternate pathways for myocardial fuel oxidation could unveil novel strategies to treat heart failure. Methods and Results—: Quantitative mitochondrial proteomics was used to identify energy metabolic derangements that occur during the development of cardiac hypertrophy and heart failure in well-defined mouse models. As expected, the amounts of proteins involved in fatty acid utilization were downregulated in myocardial samples from the failing heart. Conversely, expression of β-hydroxybutyrate dehydrogenase 1, a key enzyme in the ketone oxidation pathway, was increased in the heart failure samples. Studies of relative oxidation in an isolated heart preparation using ex vivo nuclear magnetic resonance combined with targeted quantitative myocardial metabolomic profiling using mass spectrometry revealed that the hypertrophied and failing heart shifts to oxidizing ketone bodies as a fuel source in the context of reduced capacity to oxidize fatty acids. Distinct myocardial metabolomic signatures of ketone oxidation were identified. Conclusions—: These results indicate that the hypertrophied and failing heart shifts to ketone bodies as a significant fuel source for oxidative ATP production. Specific metabolite biosignatures of in vivo cardiac ketone utilization were identified. Future studies aimed at determining whether this fuel shift is adaptive or maladaptive could unveil new therapeutic strategies for heart failure.

1 September 2005 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TKTimothy R. Koves
Timothy R. Koves
PLPing Li
Ping Li
JAJie An
Jie An
TATakayuki Akimoto
Takayuki Akimoto
DSDorothy Slentz
Dorothy Slentz
DMDeborah M. Muoio
Deborah M. Muoio
Peroxisome proliferator-activated receptor-γ co-activator 1α (PGC1α) is a promiscuous co-activator that plays a key role in regulating mitochondrial biogenesis and fuel homeostasis. Emergent evidence links decreased skeletal muscle PGC1α activity and coincident impairments in mitochondrial performance to the development of insulin resistance in humans. Here we used rodent models to demonstrate that muscle mitochondrial efficiency is compromised by diet-induced obesity and is subsequently rescued by exercise training. Chronic high fat feeding caused accelerated rates of incomplete fatty acid oxidation and accumulation of β-oxidative intermediates. The capacity of muscle mitochondria to fully oxidize a heavy influx of fatty acid depended on factors such as fiber type and exercise training and was positively correlated with expression levels of PGC1α. Likewise, an efficient lipid-induced substrate switch in cultured myocytes depended on adenovirus-mediated increases in PGC1α expression. Our results supported a novel paradigm in which a high lipid supply, occurring under conditions of low PGC1α, provokes a disconnect between mitochondrial β-oxidation and tricarboxylic acid cycle activity. Conversely, the metabolic remodeling that occurred in response to PGC1α overexpression favored a shift from incomplete to complete β-oxidation. We proposed that PGC1α enables muscle mitochondria to better cope with a high lipid load, possibly reflecting a fundamental metabolic benefit of exercise training.

8 February 2004 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JAJie An
Jie An
DMDeborah M Muoio
Deborah M Muoio
MSMasakazu Shiota
Masakazu Shiota
YFYuka Fujimoto
Yuka Fujimoto
GCGary W Cline
Gary W Cline
CNChristopher B Newgard
Christopher B Newgard

1 June 2013 in Molecular Cell
Verified
Journal Article
Closed access
GLGaëlle Laurent
Gaëlle Laurent
NGNatalie J. German
Natalie J. German
ASAsish Saha
Asish Saha
VBVincent C.J. de Boer
Vincent C.J. de Boer
MDMichael Davies
Michael Davies
MHMarcia C. Haigis
Marcia C. Haigis

1 July 2010 in Cell Metabolism
Verified
Journal Article
Closed access
JEJessica M. Ellis
Jessica M. Ellis
LLLei O. Li
Lei O. Li
PWPei-Chi Wu
Pei-Chi Wu
TKTimothy R. Koves
Timothy R. Koves
OIOlga Ilkayeva
Olga Ilkayeva
RCRosalind A. Coleman
Rosalind A. Coleman